-
-
-
-
-
-
-
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
-
-
-
-
-
-
-
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $266 at Guggenheim
-
-
-
-
-
-
-
Johnson & Johnson Q1 earnings preview: analysts eye pharma strength, legal overhang
-
-
-
-
-
-
-
J&J sees 2026 profit above Wall Street estimates despite tariffs hit, Trump pricing deal
-
-
-
-
-
-
-
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
-
-
-
-
-
-
-
J&J raises revenue guide as Q3 tops forecasts, plans to spin off Orthopaedics unit
-
1,233,818 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


